193 related articles for article (PubMed ID: 93982)
1. Combination chemotherapy trials in metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; Hanley JA
Cancer Clin Trials; 1979; 2(4):327-34. PubMed ID: 93982
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of combined cyclophosphamide and methotrexate therapy in the treatment of metastatic carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG; O'Connell MJ; Reitemeier RJ; Rubin J
Cancer Treat Rep; 1984 Apr; 68(4):665-7. PubMed ID: 6201271
[TBL] [Abstract][Full Text] [Related]
3. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281.
Sun W; Lipsitz S; Catalano P; Mailliard JA; Haller DG;
J Clin Oncol; 2005 Aug; 23(22):4897-904. PubMed ID: 16051944
[TBL] [Abstract][Full Text] [Related]
4. Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon.
Janson ET; Oberg K
Acta Oncol; 1993; 32(2):225-9. PubMed ID: 7686765
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy for metastatic carcinoid tumors: experiences with 32 patients and a review of the literature.
Legha SS; Valdivieso M; Nelson RS; Benjamin RS; Bodey GP
Cancer Treat Rep; 1977 Dec; 61(9):1699-703. PubMed ID: 597818
[TBL] [Abstract][Full Text] [Related]
6. Outcome of patients with pulmonary carcinoid tumors receiving chemotherapy or chemoradiotherapy.
Wirth LJ; Carter MR; Jänne PA; Johnson BE
Lung Cancer; 2004 May; 44(2):213-20. PubMed ID: 15084386
[TBL] [Abstract][Full Text] [Related]
7. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
[TBL] [Abstract][Full Text] [Related]
8. Treatment of the carcinoid tumor and the malignant carcinoid syndrome.
Moertel CG
J Clin Oncol; 1983 Nov; 1(11):727-40. PubMed ID: 6199469
[TBL] [Abstract][Full Text] [Related]
9. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.
Kvols LK; Moertel CG; O'Connell MJ; Schutt AJ; Rubin J; Hahn RG
N Engl J Med; 1986 Sep; 315(11):663-6. PubMed ID: 2427948
[TBL] [Abstract][Full Text] [Related]
10. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).
Gebbia V; Majello E; Testa A; Pezzella G; Giuseppe S; Giotta F; Riccardi F; Fortunato S; Colucci G; Gebbia N
Cancer; 1996 Sep; 78(6):1300-7. PubMed ID: 8826954
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy for islet cell carcinoma and metastatic carcinoid tumors with 5-fluorouracil and streptozotocin.
Chernicoff D; Bukowski RM; Groppe CW; Hewlett JS
Cancer Treat Rep; 1979 May; 63(5):795-6. PubMed ID: 222449
[TBL] [Abstract][Full Text] [Related]
13. Goblet cell carcinoid tumors (adenocarcinoid) of the appendix.
Toumpanakis C; Standish RA; Baishnab E; Winslet MC; Caplin ME
Dis Colon Rectum; 2007 Mar; 50(3):315-22. PubMed ID: 17195086
[TBL] [Abstract][Full Text] [Related]
14. The carcinoid syndrome: a treatable malignant disease.
Kvols LK
Oncology (Williston Park); 1988 Feb; 2(2):33-41. PubMed ID: 3079320
[TBL] [Abstract][Full Text] [Related]
15. Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients.
Safford SD; Coleman RE; Gockerman JP; Moore J; Feldman J; Onaitis MW; Tyler DS; Olson JA
Cancer; 2004 Nov; 101(9):1987-93. PubMed ID: 15455358
[TBL] [Abstract][Full Text] [Related]
16. Combined alpha- and gamma-interferon therapy for malignant midgut carcinoid tumors. A phase I-II trial.
Janson ET; Kauppinen HL; Oberg K
Acta Oncol; 1993; 32(2):231-3. PubMed ID: 8323762
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
Kelsen D; Gralla R; Stoopler M; Casper E; Cheng E; Kosloff C; Golbey R
Cancer Treat Rep; 1982 Feb; 66(2):247-51. PubMed ID: 7034932
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxic treatment in patients with malignant carcinoid tumors. Response to streptozocin--alone or in combination with 5-FU.
Oberg K; Norheim I; Lundqvist G; Wide L
Acta Oncol; 1987; 26(6):429-32. PubMed ID: 2451530
[TBL] [Abstract][Full Text] [Related]
19. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.
Engstrom PF; Lavin PT; Moertel CG; Folsch E; Douglass HO
J Clin Oncol; 1984 Nov; 2(11):1255-9. PubMed ID: 6238136
[TBL] [Abstract][Full Text] [Related]
20. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome.
Oberg K; Funa K; Alm G
N Engl J Med; 1983 Jul; 309(3):129-33. PubMed ID: 6191217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
